Navigation Links
Risk of cancer increases with exposure to low-dose radiation
Date:2/7/2011

Exposure to low-dose radiation from cardiac imaging and other procedures after a heart attack is associated with an increased risk of cancer, found a new study published in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100463.pdf.

The use of procedures with low-dose ionizing radiation, such as computed tomography (CT) angiography and nuclear scans, is increasing which has led to mounting concern in the medical community that patients may be at increased risk of cancer. For patients with known or suspected coronary artery disease, the trend towards increased use of these procedures is particularly strong. In many centres, these procedures are replacing those that do not use radiation, such as stress tests on exercise treadmills and echocardiography. However, little is known about the effects of exposure to radiation and the risk of cancer.

The study, conducted by researchers from the McGill University Health Centre (MUHC) and and the Jewish General Hospital in Montral, Quebec, looked at data on 82 861 patients who had a heart attack between April 1996 and March 2006 but no history of cancer. Of this number, 77% underwent at least one cardiac procedure with low-dose ionizing radiation within one year of the attack.

"We found a relation between the cumulative exposure to low-dose ionizing radiation from cardiac imaging and therapeutic procedures after acute myocardial infarction, and the risk of incident cancer," writes Dr. Louise Pilote, researcher in epidemiology at the Research Institute of the MUHC and director of the Division of Internal Medicine at the MUHC with coauthors. "Although most patients were exposed to low or moderate levels of radiation, a substantial group were exposed to high levels and in general tended to be younger male patients with fewer comorbidities."

The median age of patients was 63.2 years and 31.7% were women. Patients whose treating physician was a cardiologist had higher levels of exposure to radiation compared with those whose treating physician was a general practitioner. There were 12 020 incident cancers detected during follow up, with two-thirds of the cancers affecting the abdomen/pelvis and chest areas. "These results call into question whether our current enthusiasm for imaging and therapeutic procedures after acute myocardial infarction should be tempered," conclude the authors. "We should at least consider putting into place a system of prospectively documenting the imaging tests and procedures that each patient undergoes and estimating his or her cumulative exposure to low-dose ionizing radiation."

In a related commentary, http://www.cmaj.ca/embargo/cmaj101885.pdf Mathew Mercuri, McMaster University, and coauthors write that, although the radiation exposure of many tests is often low, "the frequency with which such tests are performed may pose a population risk." They state the best solution may be prevention, which could mean using procedures with lower or no radiation exposure, especially if there are multiple procedures involved. They call for programs to track radiation doses to help patients and physicians track the risk of cumulative exposure.


'/>"/>

Contact: Kim Barnhardt
kim.barnhardt@cmaj.ca
613-520-7116 x2224
Canadian Medical Association Journal
Source:Eurekalert

Related medicine news :

1. Protein may be key to new treatment in a childhood cancer
2. Urine-sniffing dogs: Early detection of prostate cancer
3. Heart Scans May Raise Cancer Risk, Study Finds
4. Breast Cancer Treatment May Lead to Hip Fracture
5. Improving care for bowel cancer patients
6. Cancer on the Rise in Developing Countries: Report
7. Report says economic development could change worldwide face of cancer
8. New induced stem cells may unmask cancer at earliest stage
9. Healthier Lifestyles May Prevent 340,000 U.S. Cancers a Year: Study
10. Destined for disease: Breast cancer mutation regulates cell fate
11. CSHL study unmasks a stem cell origin of skin cancer and the genetic roots of malignancy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... Ellevate Network, the ... business to advocate for action towards gender equality at their inaugural Summit in New ... the globe, and reached a social audience of over 3 million. To watch the ...
(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, ... a medical article to the newly revamped Cosmetic Town journal section, ... hair transplant procedure known as Follicular Unit Extraction (FUE). , Dr. ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Sept. 28, 2017 Cohen Veterans Bioscience and ... use of wearable and home sensors for real-time monitoring ... Signal Foundation, a nonprofit organization focused on disruptive health ... an affordable analytical system to record and integrate behavioral, ... ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
(Date:9/19/2017)... -- HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy ... team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D ...
Breaking Medicine Technology: